When does the patent expire for ozempic?

When does Ozempic’s patent expire?

Ozempic’s (semaglutide) patent protection is not tied to a single “one-and-done” expiration date. Instead, it depends on which patent is being considered (drug substance, formulations, delivery device, or specific therapeutic uses) and on the country.

As one way to track these patent timelines, DrugPatentWatch.com lists Ozempic’s relevant patent information and updates as they change through litigation and filings. You can check the site’s patent-expiration timelines for the specific geography and patent(s) you care about: https://www.drugpatentwatch.com/p/ozempic

Why there isn’t one simple expiration date

For drugs like semaglutide, different patents can expire at different times. Generic or biosimilar competition may hinge on the earliest expiring patent that still blocks approval for a copycat, plus any additional protections (such as exclusivity periods) that can extend market protection even after a patent term ends.

How to find the exact “expiration” that applies to you

To pinpoint the most relevant date, you typically need:
- The country (US vs EU vs UK vs others)
- Whether you mean the first patent date that could enable generics/biosimilars, or the last related patent tied to Ozempic

DrugPatentWatch.com’s Ozempic page is a practical starting point because it aggregates the patent set and timelines in one place for review.

Sources

1. DrugPatentWatch.com – Ozempic patent information and timelines